XML 88 R35.htm IDEA: XBRL DOCUMENT v3.24.2.u1
STOCKHOLDERS’ EQUITY (Details Narrative) - $ / shares
1 Months Ended 6 Months Ended 12 Months Ended
May 31, 2023
Jun. 30, 2024
Dec. 31, 2023
Dec. 26, 2023
Oct. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Class of Stock [Line Items]              
Preferred stock, shares authorized   5,000,000 5,000,000     5,000,000  
Preferred stock, par value   $ 0.0001 $ 0.0001     $ 0.0001  
Preference shares, shares issued   0 0     0  
Preferred stock, shares outstanding   0 0     0  
Common Stock [Member]              
Class of Stock [Line Items]              
Common stock, par value       $ 0.0001      
Aspire Biopharma Inc [Member]              
Class of Stock [Line Items]              
Common stock, shares authorized 750,000,000            
Common stock, par value   $ 0.01 $ 0.01     $ 0.01  
Common stock, shares outstanding   443,000,000 443,000,000     443,000,000  
Common stock, voting rights   Each common share entitles the holder to one vote on any matter on which action of the stockholders of the corporation is sought. Each common share entitles the holder to one vote on any matter on which action of the stockholders of the corporation is sought.        
Stock split 20:1            
Warrants outstanding   7,500,000 47,500,000     40,000,000  
Aspire Biopharma Inc [Member] | Common Stock [Member]              
Class of Stock [Line Items]              
Common stock, shares authorized 750,000,000            
Common stock, par value   $ 0.005          
Aspire Biopharma Inc [Member] | Seven Parties [Member]              
Class of Stock [Line Items]              
Issuance of warrants     7,500,000       26,000,000
Average per share price     $ 0.02       $ 0.004
Aspire Biopharma Inc [Member] | Shareholder [Member]              
Class of Stock [Line Items]              
Common stock, shares issued           2,000,000  
Aspire Biopharma Inc [Member] | Three Parties [Member]              
Class of Stock [Line Items]              
Issuance of warrants           14,000,000  
Average per share price           $ 0.01  
Common Class A [Member]              
Class of Stock [Line Items]              
Common stock, shares authorized   300,000,000 300,000,000     300,000,000  
Common stock, par value   $ 0.0001 $ 0.0001     $ 0.0001  
Common stock, shares issued   7,187,500 7,187,500     0  
Common stock, shares outstanding   7,187,500 7,187,500     0  
Common Class A [Member] | Aspire Biopharma Inc [Member]              
Class of Stock [Line Items]              
Common stock, par value     $ 0.005     $ 0.005  
Class A Ordinary Shares Subject To Possible Redemption [Member]              
Class of Stock [Line Items]              
Ordinary shares subject to possible redemption, shares issued   577,644 1,803,729        
Ordinary shares subject to possible redemption, shares outstanding   577,644 1,803,729     28,750,000  
Common Class B [Member]              
Class of Stock [Line Items]              
Common stock, shares authorized   50,000,000 50,000,000     50,000,000  
Common stock, par value   $ 0.0001 $ 0.0001     $ 0.0001  
Common stock, shares issued   0 0     7,187,500  
Common stock, shares outstanding   0 0     7,187,500  
Ratio to be applied to the stock in the conversion   20.00% 20.00%        
Common stock, voting rights     one        
Series A Preferred Stock [Member] | Aspire Biopharma Inc [Member]              
Class of Stock [Line Items]              
Preferred stock, shares authorized         25,000,000    
Preferred stock, par value         $ 0.0001    
Preferred stock, shares outstanding   322,059 0        
Common stock, shares authorized   750,000,000 750,000,000        
Common stock, par value   $ 0.005 $ 0.01